Torrent Pharmaceuticals to acquire 100% of Curatio Healthcare for Rs 2,000 crores

Ahmedabad-based Torrent Pharmaceuticals Limited has entered into a definitive agreement to acquire 100% of skincare manufacturer Curatio Healthcare for Rs. 2,000 crores.

Skincare product maker- Curatio has a strong presence in the cosmetic dermatology segment with a portfolio of over 50 brands, marketed in India. Curatio’s portfolio consists of leading brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite, which are ranked amongst top 5 brands in their covered market.

With this acquisition, Torrent Pharma will enter the league of top 10 players in the dermatology segment and will be the leader in the cosmetic dermatology space.

“We are delighted to enter into this deal with Curatio. The acquisition offers Torrent the opportunity to enhance its presence in dermatology with a differentiated portfolio and is a strong strategic fit. Curatio has built a commendable set of high market share brands in cosmetic and pediatric dermatology that we look forward to adding to our product offerings,” Aman Mehta, director, Torrent pharma said in a statement.

The transaction is expected to close within one month.

(With inputs from health)